These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25996066)

  • 1. Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.
    Ramamoorthi R; Graef KM; Dent J
    Future Med Chem; 2015; 7(6):727-35. PubMed ID: 25996066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-based molecular modeling strategies for schistosomiasis drug discovery.
    Ferreira LG; Oliva G; Andricopulo AD
    Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel: do we need another antischistosoma treatment?
    Fenwick A
    Future Med Chem; 2015; 7(6):677-80. PubMed ID: 25996058
    [No Abstract]   [Full Text] [Related]  

  • 5. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-positioning protein-kinase inhibitors against schistosomiasis.
    Gelmedin V; Dissous C; Grevelding CG
    Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
    Spangenberg T
    ACS Infect Dis; 2021 May; 7(5):939-942. PubMed ID: 32819092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
    Lee EF; Fairlie WD
    Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 12. Antischistosomal agents: state of art and perspectives.
    Lago EM; Xavier RP; Teixeira TR; Silva LM; da Silva Filho AA; de Moraes J
    Future Med Chem; 2018 Jan; 10(1):89-120. PubMed ID: 29235368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency.
    Cenderello G; Di Biagio A; Riccardi N; Taramasso L; De Maria A; Cassola G; Viscoli C
    New Microbiol; 2016 Oct; 39(4):299-300. PubMed ID: 27551726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 16. Schistosomiasis elimination by 2020 or 2030?
    Fenwick A; Jourdan P
    Int J Parasitol; 2016 Jun; 46(7):385-8. PubMed ID: 26907938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of antimicrobial peptides for treatment of human schistosomiasis.
    Oyinloye B; Adenowo F; Gxaba N; Kappo A
    Curr Drug Targets; 2014; 15(9):852-9. PubMed ID: 25101908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosomiasis and its treatment.
    Caffrey CR
    Future Med Chem; 2015; 7(6):675-6. PubMed ID: 25996057
    [No Abstract]   [Full Text] [Related]  

  • 19. Something old, something new: is praziquantel enough for schistosomiasis control?
    Secor WE; Montgomery SP
    Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059
    [No Abstract]   [Full Text] [Related]  

  • 20. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.